ATE516015T1 - Galenische form zur oralen transmukosalen zuführung von triptanen - Google Patents

Galenische form zur oralen transmukosalen zuführung von triptanen

Info

Publication number
ATE516015T1
ATE516015T1 AT09706112T AT09706112T ATE516015T1 AT E516015 T1 ATE516015 T1 AT E516015T1 AT 09706112 T AT09706112 T AT 09706112T AT 09706112 T AT09706112 T AT 09706112T AT E516015 T1 ATE516015 T1 AT E516015T1
Authority
AT
Austria
Prior art keywords
active ingredient
triptanes
transmucosal delivery
oral transmucosal
galenic form
Prior art date
Application number
AT09706112T
Other languages
English (en)
Inventor
Philippe Perovitch
Marc Maury
Original Assignee
Philippe Perovitch
Marc Maury
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philippe Perovitch, Marc Maury filed Critical Philippe Perovitch
Application granted granted Critical
Publication of ATE516015T1 publication Critical patent/ATE516015T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT09706112T 2008-01-30 2009-01-29 Galenische form zur oralen transmukosalen zuführung von triptanen ATE516015T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0850571A FR2926721B1 (fr) 2008-01-30 2008-01-30 Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
PCT/FR2009/050134 WO2009095621A1 (fr) 2008-01-30 2009-01-29 Forme galenique pour l'administration de triptans par voie trans-muqueuse buccale

Publications (1)

Publication Number Publication Date
ATE516015T1 true ATE516015T1 (de) 2011-07-15

Family

ID=39766922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09706112T ATE516015T1 (de) 2008-01-30 2009-01-29 Galenische form zur oralen transmukosalen zuführung von triptanen

Country Status (15)

Country Link
US (1) US9801815B2 (de)
EP (1) EP2252263B1 (de)
JP (1) JP5435659B2 (de)
CN (1) CN101983052B (de)
AT (1) ATE516015T1 (de)
BR (1) BRPI0907203A2 (de)
CA (1) CA2713163C (de)
DK (1) DK2252263T3 (de)
ES (1) ES2369747T3 (de)
FR (1) FR2926721B1 (de)
MX (1) MX2010008285A (de)
PL (1) PL2252263T3 (de)
PT (1) PT2252263E (de)
RU (1) RU2492852C2 (de)
WO (1) WO2009095621A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3031668A1 (fr) 2015-01-20 2016-07-22 Philippe Perovitch Dispositif d'administration d'un principe actif par voie per-muqueuse buccale.
FR3053244A1 (fr) 2016-07-01 2018-01-05 Philippe Perovitch Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
IT1291895B1 (it) * 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
JP3350061B2 (ja) * 1997-07-03 2002-11-25 ファイザー・インク エレトリプタンヘミスルフェートおよびカフェインを含有する医薬組成物
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
GB9816556D0 (en) * 1998-07-30 1998-09-30 Pfizer Ltd Therapy
WO2007070504A2 (en) * 2005-12-13 2007-06-21 Morton Grove Pharmaceuticals, Inc. Stable and palatable oral liquid sumatriptan compositions
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs

Also Published As

Publication number Publication date
JP5435659B2 (ja) 2014-03-05
PL2252263T3 (pl) 2011-12-30
PT2252263E (pt) 2011-10-19
CN101983052B (zh) 2013-03-20
MX2010008285A (es) 2010-10-04
FR2926721B1 (fr) 2011-07-22
FR2926721A1 (fr) 2009-07-31
DK2252263T3 (da) 2011-10-31
EP2252263A1 (de) 2010-11-24
US20100298401A1 (en) 2010-11-25
WO2009095621A1 (fr) 2009-08-06
RU2492852C2 (ru) 2013-09-20
CA2713163A1 (fr) 2009-08-06
US9801815B2 (en) 2017-10-31
ES2369747T3 (es) 2011-12-05
BRPI0907203A2 (pt) 2015-07-14
EP2252263B1 (de) 2011-07-13
CN101983052A (zh) 2011-03-02
RU2010136277A (ru) 2012-03-10
CA2713163C (fr) 2016-11-08
JP2011510962A (ja) 2011-04-07

Similar Documents

Publication Publication Date Title
MX2009003030A (es) Forma galenita para la administracion por via transmucosa de principios activos.
PL1998762T3 (pl) Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
MX2009002314A (es) Composiciones farmaceuticas que comprenden hgh para suministro oral.
CY1118661T1 (el) Φαρμακευτικη συνθεση, φαρμακευτικη δοσολογικη μορφη, διαδικασια για την παρασκευη τους, μεθοδοι για αντιμετωπιση και χρησεις αυτων
DE602007007991D1 (de) Kleinvolumige, orale, transmukosale dosierungsformen mit sufentanil zur schmerzbehandlung
CL2011000642A1 (es) Unidad de dosificacion que comprende 25 a 400 mg del acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico; kit farmaceutico que comprende la unidad de dosificacion; y su uso para el tratamiento de fibrosis quistica.
BRPI0820520B8 (pt) processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos
UA102534C2 (xx) ТВЕРДА ФОРМА 3-(6-(1-(2,2-ДИФТОРБЕНЗО$d]$1,3]-ДІОКСОЛ-5-ІЛ)-ЦИКЛОПРОПАНКАРБОКСАМІДО)-3-МЕТИЛПІРИДИН-2-ІЛ)БЕНЗОЙНОЇ КИСЛОТИ (ВАРІАНТИ)$ТВЕРДАЯ ФОРМА 3-(6-(1-(2,2-ДИФТОРБЕНЗО$d]$1,3]-ДИОКСОЛ-5-ИЛ)-ЦИКЛОПРОПАНКАРБОКСАМИДО)-3-МЕТИЛПИРИДИН-2-ИЛ)БЕНЗОЙНОЙ КИСЛОТЫ (ВАРИАНТЫ)
MX2013003635A (es) Compuestos de n-heteroarilo.
TR200806298A2 (tr) Farmasötik formülasyon
EA201390394A1 (ru) Никотинсодержащий состав
UA101407C2 (ru) Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат
DE602004016403D1 (de) Topische pharmazeutische Zusammensetzungen enthaltend aktive natürliche Bestandteile zur Verhütung und Behandlung von mucosalen Entzündungprozessen
WO2008087323A8 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
MX2012000954A (es) Composicion far,aceutica topica que incuye la rel-n-[6-[(2r,6s)-2,6-dimetil-4-morfolinil]-3-piridinil]-2-metil- 4'-(trifluoro-metoxi)-[1,1'-bifenil]-3-carboxamida.
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
EA201270573A1 (ru) Гранулированный в расплаве цинакальцет
MX2011006797A (es) Una formulación para administración oral transmucósica de fármacos reductores de lípidos.
BRPI0411702B8 (pt) uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral
ATE516015T1 (de) Galenische form zur oralen transmukosalen zuführung von triptanen
EA201390950A1 (ru) Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon
MA32722B1 (fr) Formulation galénique renfermant de l'aliskirène et procédé associé de préparation par granulation par fusion-extrusion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2252263

Country of ref document: EP